Carly Kenselaar

Stock Analyst at Citigroup

(3.07)
# 1,206
Out of 4,757 analysts
6
Total ratings
80%
Success rate
65.6%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Carly Kenselaar

Travere Therapeutics
Feb 24, 2025
Maintains: Buy
Price Target: $31$35
Current: $18.94
Upside: +84.79%
Krystal Biotech
Oct 12, 2023
Initiates: Buy
Price Target: $160
Current: $178.93
Upside: -10.58%